Sesamin attenuates intestinal injury in sepsis via the HMGB1/TLR4/IL-33 signalling pathway

• Auteurs principaux: Zhi-Ling Li (Auteur), Min Gao (Auteur), Ming-Shi Yang (Auteur), Xue-Fei Xiao (Auteur), Jing-Jing Liu (Auteur), Bing-Chang Yang (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Context Sepsis is currently one of the leading causes of death in intensive care units (ICUs). Sesamin was previously reported to inhibit inflammation. However, no studies have revealed the impact of sesamin on sepsis. Objective We studied the mechanism underlying the effect of sesamin on the pathop...